tiprankstipranks
Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market
Want to see AU:PTX full AI Analyst Report?

Prescient Therapeutics Limited (PTX) Financial Statements

22 Followers

Prescient Therapeutics Limited Financial Overview

Prescient Therapeutics Limited's market cap is currently AU$71.50M. The company's EPS TTM is AU$-0.0069; its P/E ratio is -9.86; Prescient Therapeutics Limited is scheduled to report earnings on August 20, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total RevenueAU$ 0.00AU$ 4.36MAU$ 3.71MAU$ 2.43MAU$ 1.89M
Gross ProfitAU$ -110.34KAU$ 4.36MAU$ 3.71MAU$ 2.43MAU$ 1.89M
Operating IncomeAU$ -10.59MAU$ -7.54MAU$ -7.19MAU$ -9.89MAU$ -7.10M
EBITDAAU$ -10.48MAU$ -7.54MAU$ -7.19MAU$ -7.46MAU$ -6.86M
Net IncomeAU$ -7.00MAU$ -7.32MAU$ -8.24MAU$ -7.00MAU$ -5.12M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 9.03MAU$ 6.93MAU$ 14.51MAU$ 21.92MAU$ 12.28M
Total AssetsAU$ 16.28MAU$ 14.56MAU$ 20.39MAU$ 28.11MAU$ 17.62M
Total DebtAU$ 222.97KAU$ 0.00AU$ 330.49KAU$ 0.00AU$ 0.00
Net DebtAU$ -8.81MAU$ -6.91MAU$ -10.16MAU$ -5.90MAU$ -12.26M
Total LiabilitiesAU$ 2.08MAU$ 3.17MAU$ 2.33MAU$ 2.03MAU$ 856.01K
Stockholders' EquityAU$ 14.20MAU$ 11.39MAU$ 18.07MAU$ 26.08MAU$ 16.76M
Cash Flow
Free Cash FlowAU$ -7.22MAU$ -7.24MAU$ -7.40MAU$ -6.19MAU$ -4.32M
Operating Cash FlowAU$ -7.22MAU$ -7.24MAU$ -7.40MAU$ -6.19MAU$ -4.31M
Investing Cash FlowAU$ 0.00AU$ 4.00MAU$ 12.00MAU$ -16.00MAU$ -4.43K
Financing Cash FlowAU$ 9.34MAU$ -330.49KAU$ 18.15KAU$ 15.83MAU$ 428.29K
Currency in AUD

Prescient Therapeutics Limited Earnings and Revenue History

Prescient Therapeutics Limited Debt to Assets

Prescient Therapeutics Limited Cash Flow

Prescient Therapeutics Limited Forecast EPS vs Actual EPS